Pulmonary Disease Doctors in Warner Robins, GA Accepting Medicare

3 Pulmonary Disease doctors found. Showing 1 - 3

Hatem Abed Asad, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 105 Briarcliff Rd, Suite B, Warner Robins, GA 31088 Phone: 478-922-8900    Fax: 478-922-8989

Maya Hosein, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 512 S Houston Lake Rd, Warner Robins, GA 31088 Phone: 478-254-2644    Fax: 478-254-4924

Dr. Charles S Edenfield, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 623 S Houston Lake Rd, Suite 200, Warner Robins, GA 31088 Phone: 478-922-9842    Fax: 478-923-8444

News Archive

AAPC announces results from 2012 health care salary survey

AAPC, the leader in enabling the business side of medicine, announced the results from the 2012 AAPC Health Care Salary Survey. The survey is open to all members of the health care community, including medical billers and coders, practice managers, auditors, and physicians. This year nearly 20,000 health care professionals responded to the survey.

Implementing population level changes could avoid up to 50% of deaths from CVD

Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).

New tool may hold key to personalized medicine applications in the future

ather than your average bowl of Lucky Charms, these are three-dimensional cell cultures generated by an exciting new digital microfluidics platform, the results of which have been published in Nature Communications this week by researchers at the University of Toronto.

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.

lululemon athletica second-quarter net revenue increases 55.8% to $152.2 million

lululemon athletica inc. today announced financial results for the second quarter ended August 1, 2010.

Read more Medical News

› Verified 3 days ago